Pharmaceutical Drying: Controlled Climate Solutions for Critical Drying Processes

Pharma | Solutions

Controlled Climate Solutions for Critical Drying Processes

In the pharmaceutical industry, drying is one of the most climate-critical steps in the entire production process. Whether it involves active pharmaceutical ingredients (APIs), botanical extracts, or intermediates – drying these materials demands precise and uninterrupted control of both temperature and relative humidity.

Deviations in these parameters have direct consequences for product quality: changes in crystal structure, loss of active compounds, or batch-to-batch variation that complicates GMP validation.

Revomax supplies the climate component that enables integrators and OEM manufacturers of drying rooms and drying systems to guarantee this level of control – consistently, batch after batch.

 

The Challenge

The greatest challenge in pharma drying is not reaching the right conditions, it is maintaining them throughout the entire drying process.

Common configurations combine HVAC systems with standalone dehumidifiers. This approach introduces structural limitations:

  • Temperature and humidity are controlled separately and continuously interfere with each other
  • Systems operate on on/off cycles, causing measurable fluctuations
  • Dehumidification is tied to the cooling cycle and stops once the temperature setpoint is reached
  • Low RH values are difficult to maintain without introducing temperature deviations
  • Slow system response makes correction during the process impossible

The result: a drying environment with continuously varying conditions – making standardization, optimization, and GMP validation significantly more difficult.

Our Approach

Revomax Air Cooled is not an HVAC component.

It is an integrated climate system developed for process-critical applications where stability is non-negotiable.

The system controls temperature, relative humidity, and air distribution simultaneously and continuously from a single integrated control strategy. There are no separate components interfering with each other – all parameters are maintained in mutual balance.

Through the use of inverter technology, Revomax does not operate on traditional on/off cycles but in a continuous, modulating mode. The system constantly adjusts its capacity to match the actual process demand, creating a true steady-state climate.

Critical for pharma drying: the dehumidification function remains active even after the temperature setpoint has been reached. This enables targeted moisture removal without introducing unwanted temperature changes.

 

Key Performance

Revomax delivers the following specified performance in pharma drying applications:

 

Parameter Performance
Temperature stability +/- 1.0 C around setpoint
RH stability +/- 4% RH around setpoint
Dehumidification Continuous, independent of cooling demand
Control mode Modulating – no on/off behavior
Air distribution Uniform throughout the entire space
System design Closed loop, independent of external climate conditions

 

A fully integrated remote access and intelligence layer enables complete system control via WiFi/LAN, combined with advanced monitoring, reporting, and alerting. This ensures continuous visibility of critical parameters, supports validation and compliance, and allows immediate intervention to maintain a fully controlled and traceable drying process.

These results are reproducible across batches and provide a stable foundation for IQ/OQ/PQ validation within GMP environments.

 

Results

A stable and controlled drying climate translates directly into improved process performance and product quality.

Process:

  • Fully predictable and reproducible drying curves
  • Direct control over drying time and process parameters
  • Ability to optimize processes based on stable, reliable data

Quality:

  • Consistent product properties across batches
  • Preservation of active compounds and chemical stability
  • Uniform end products without internal variation

Operational:

  • Simplified climate system through integration of T, RH, and air distribution
  • Lower energy costs through efficient, modulating operation
  • Demonstrably stable environmental conditions – easier to document and validate within GMP
  • Direct integration into existing systems of integrators and OEM manufacturers

Why Revomax Air Cooled for Pharma Drying

The Air Cooled Revomax was developed specifically for environments where climate stability has a direct impact on product quality and process validation.

For integrators and OEM manufacturers of pharma drying systems, this means:

  • One integrated system for complete climate control (T, RH, air distribution)
  • Specified and reproducible performance: +/- 1.0 C / +/- 4% RH
  • Continuous dehumidification as the core of the drying process
  • Steady-state operation without fluctuations – no on/off behavior
  • Suitable for cleanroom and GMP applications
  • Supports IQ/OQ/PQ validation programs
  • Proven solution with minimal integration risk

 

Conclusion

Pharma drying requires more than capacity. It demands a climate system that not only reaches the right conditions, but demonstrably and reproducibly maintains them – throughout the entire drying process, batch after batch.

Revomax gives integrators and OEM manufacturers a component that makes this structurally possible: stable, validatable, and built for the highest demands of the pharmaceutical industry.

Are you an integrator or system builder active in pharma drying? Contact us to discuss how Revomax Air Cooled fits into your system.

“What we see in practice is that existing systems may have sufficient capacity, but fail to deliver the stability that critical drying processes require. Once temperature and humidity are controlled simultaneously and continuously from a single system, the situation changes fundamentally. The process becomes predictable, batch variation decreases, and validation becomes significantly easier. That is exactly what our customers in pharma need.”

Pharmaceutical Drying Ronald vd Oudeweetering (CTO / Founder)
© 2026 Airlux Technologies VAT: NL 852252729 B01 | Chamber of Commerce: 56674651 Privacy & Cookie Policy (EU) | Terms & Conditions